Neurontin Fraudulent Marketing Class Action

TBS represented a national class of insurance providers alleging that in an effort to boost profits, Pfizer, Inc. and Warner-Lambert Co. sold the drug Neurontin for uses for which it was neither approved by the U.S. Food and Drug Administration nor medically effective. Pfizer Inc. agreed to pay $325 million to resolve the class’s claim that Pfizer defrauded insurers and other healthcare benefit providers by its off label marketing of Neurontin.

Case Documents

Chase...thank you for your professional assistance in the resolution of the recent lawsuit against me. I could not have obtained such a favorable outcome without your assistance even though I am a lawyer myself and have handled similar matters during my over 40 year legal career.

You have saved me tens of thousands of dollars over what I could have obtained had I tried to handle the matter myself. With hundreds of thousands of dollars at stake you were worth every penny of your most reasonable fee. Beyond that was the peace of mind for both me and my wife during the process, and you can’t put a price tag on that. Your knowledge and expertise were much appreciated.
Stanley R. Byrd Contact Us
Janissa - I would never talk to any lawyer about anything until I talk to you first. You are just simply AMAZING and not only did you go completely above and beyond to ensure my daughter's trust was safe and secure, but every time I thought I couldn't go on, you constantly assured me that everything would be all right.
Sophia Cosola Contact Us
Kevin is a great fit for the issue he helped with and continues to help with. We have followed him from another firm to TBS and have worked with him for 10 years now...I appreciate Kevin and what he continues to do to assist us.
Leif Langlois Contact Us